https://www.marketscreener.com/quote/stock/APREA-THERAPEUTICS-INC-53920918/news/Aprea-Therapeutics-FDA-Lifts-Hold-on-Eprenetapopt-Study-in-Lymphoid-Malignancies-37270348/?utm_source=telegram&utm_medium=social&utm_campaign=share